Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Medtronic
Boehringer Ingelheim
Express Scripts
Mallinckrodt

Last Updated: January 27, 2020

DrugPatentWatch Database Preview

Amneal Pharms Co Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for AMNEAL PHARMS CO, and what generic and branded alternatives to AMNEAL PHARMS CO drugs are available?

AMNEAL PHARMS CO has forty-three approved drugs.

There are three tentative approvals on AMNEAL PHARMS CO drugs.

Summary for Amneal Pharms Co
US Patents:0
Tradenames:42
Ingredients:42
NDAs:43

Drugs and US Patents for Amneal Pharms Co

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Co PARICALCITOL paricalcitol SOLUTION;INTRAVENOUS 206699-001 Mar 9, 2017 AP RX No No   Start Trial   Start Trial
Amneal Pharms Co DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 208105-004 Mar 17, 2016 AB RX No No   Start Trial   Start Trial
Amneal Pharms Co TADALAFIL tadalafil TABLET;ORAL 209744-002 Mar 26, 2019 AB RX No No   Start Trial   Start Trial
Amneal Pharms Co TIAGABINE HYDROCHLORIDE tiagabine hydrochloride TABLET;ORAL 208181-003 Dec 8, 2017 AB RX No No   Start Trial   Start Trial
Amneal Pharms Co CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 209755-004 Sep 10, 2018 AB RX No No   Start Trial   Start Trial
Amneal Pharms Co ALBUTEROL SULFATE albuterol sulfate TABLET;ORAL 208804-001 May 21, 2018 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for AMNEAL PHARMS CO drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 1 mg/mL, 50 mL vials ➤ Subscribe 2011-12-16
➤ Subscribe Injection 100 mg/mL, 2.5 mL vials ➤ Subscribe 2007-09-24
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Harvard Business School
Moodys
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.